Stock Updates

Today’s Top Gainers in the Market Edwards Lifesciences Corp. (NYSE:EW) from Healthcare

Today’s top gainers include the company Edwards Lifesciences Corp. (NYSE:EW) which is in the industry Medical Appliances & Equipment, gaining -0.28% today. In the last week its performance is 0.83%, and 7.89% for the past quarter. Currently, Edwards Lifesciences Corp., EW has a target price of 123.95, so today’s gain of -0.28% is a significant step towards its target price. The GAP today is therefore -0.18%.

Edwards Lifesciences Corp. (NYSE:EW), has a market cap of 24380.02, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 87.70%.

At the current price of 113.6, it has a dividend yield of *TBA, and its target price is 123.95. This is with a profit margin of 19.30%, and total debt/equity of 0.24. Edwards Lifesciences Corp. (NYSE:EW) has a P/E of 47.13, as well as a forward P/E of 33.51.

With a current EPS of 2.42, and a forecasted EPS growth for next year at 18.50%,Edwards Lifesciences Corp. (NYSE:EW) has had a EPS growth for the past five years at 19.70%. For the next five years EPS growth is projected to be 17.68%.

Performance for the year is 58.09%. Since its IPO date on 3/27/2000, the total performance to date is 44.24%.

Volume today for Edwards Lifesciences Corp. (NYSE:EW), is 422874, while its average volume is 1667.76. Whilst the total gain today was -0.28%, it did have a day high of -3.29%.

Volatility for this week has been at 1.28%, and 1.51% for the month. The 52-week low for Edwards Lifesciences Corp., EW has been 81.67%, while the 52-week-high has reached -3.29%.

Looking at its return of investments, which is 15.90%, and its return on assets is 13.30%. Edwards Lifesciences Corp. (NYSE:EW) has an operating margin of 24.40%. With a sales growth of 23.10% quarter over quarter. Bearing in mind that Edwards Lifesciences Corp., EW is in the sector Healthcare, its long-term debt/equity is 0.24, and has a current ratio of 4.2 and 3.4 for quick ratio.

So what is the value of Edwards Lifesciences Corp.? Well its PEG is 2.67, and the P/S is 8.89, along with a P/B of 9.78. Meanwhile it has a p/cash of 23.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment